Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | WVE | VSTM |
|---|---|---|
| Price | $3.54 | $8.27 |
| Change today | ▲ 0.57% | ▲ 6.65% |
| Market cap | $697.55M | $748.51M |
| Return, 3 months | -43.9% | +53.1% |
| Return, year to date | -79.2% | +7.1% |
| Return, 1 year | -51.8% | -7.6% |
| P/E (TTM) | -3.3 | -3.4 |
| P/B | 1.5 | 15.0 |
| P/E percentile vs own 5y | 64th | 2nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -73.9% | +1,775.4% |
| Net profit growth (YoY) | -37.4% | -33.7% |
| Gross margin | – | 86.4% |
| Operating margin | -333.4% | -182.6% |
| Net margin | -309.7% | -231.6% |
| Return on equity | -68.3% | -471.2% |
| Analyst target vs. price | +416.1% | +81.5% |
| Analyst buy share | 92% | 100% |
| RSI (14) | 27 | 60 |
| 30-day volatility | 44.9% | 53.1% |
| Max drawdown, 1 year | -83.5% | -67.6% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
